Efficacy and Safety of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL

Abroad (travel likely)RecruitingPHASE2

Conditions

Diffuse Large B-Cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Weili Zhao) · zwl_trial@163.com · 008602164370045

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Plasmablastic Lymphoma · Ann Arbor Stage I Diffuse Large B-Cell Lymphoma · Ann Arbor Stage II Diffuse Large B-Cell Lymphoma

Abroad (travel likely)RecruitingEARLY_PHASE1

Miami, United States · Chicago, United States

A-RGEMOX in the Treatment of Early Relapsed/Refractory DLBCL

Diffuse Large B-cell Lymphoma Recurrent · Diffuse Large B Cell Lymphoma Refractory

Abroad (travel likely)RecruitingPHASE2

Hangzhou, China

Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype

Richter Syndrome · Diffuse Large B-Cell Lymphoma · Chronic Lymphocytic Leukemia

Abroad (travel likely)RecruitingPHASE2

Buffalo, United States

Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse

Diffuse Large B-cell Lymphoma Refractory · Refractory Primary Mediastinal Large B-Cell Lymphoma · Refractory Transformed B-cell Non-Hodgkin Lymphoma

Abroad (travel likely)RecruitingPHASE2

Créteil, France · Dijon, France